Noradrenalin Abcur (Noradrenaline Tartrate)

Noradrenaline acts as a direct agonist at alpha‑1 and beta‑1 adrenergic receptors. Alpha‑1 stimulation causes vasoconstriction, raising systemic vascular resistance, while beta‑1 activation enhances myocardial contractility and heart rate. The combined effect quickly elevates arterial pressure and improves organ perfusion during circulatory collapse.

The appropriate dose of Noradrenalin Abcur is individualized by the prescribing clinician. Dosing is typically initiated as a low-rate intravenous infusion and titrated based on the patient’s blood pressure response, underlying condition, and concurrent therapies. Exact milligram‑per‑minute values are defined in the physician’s order and adjusted as needed.

Safety data for noradrenaline in pregnancy and lactation are limited, and the product is classified as having an unknown pregnancy category. Use during pregnancy or while breastfeeding should only occur when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and under close medical supervision.

To place an order, submit an enquiry on the Noradrenalin Abcur product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details—including cold‑chain logistics if needed—and the necessary import documentation.

Noradrenaline is the preferred first‑line agent for most forms of distributive shock because of its potent alpha‑1 vasoconstrictive activity combined with modest beta‑1 stimulation. Compared with dopamine, it has a more predictable effect on blood pressure and fewer arrhythmic risks. Epinephrine provides stronger beta‑1 activity but may increase heart rate more markedly, making noradrenaline a safer choice for many critically ill patients.

Noradrenalin Abcur must be stored refrigerated at 2‑8 °C. The vials should be kept in their original packaging, protected from light, and must not be frozen or shaken. Before administration, the solution should be allowed to reach room temperature and inspected for particulate matter or discoloration.

The product is supplied as a sterile solution for intravenous injection. It is usually administered via a controlled infusion pump, allowing precise titration of the infusion rate. Healthcare professionals insert an IV line, connect the infusion set, and adjust the flow based on continuous blood pressure monitoring to achieve the desired hemodynamic target.

The most critical adverse events include life‑threatening arrhythmias, myocardial ischemia due to increased cardiac workload, and severe peripheral vasoconstriction that can lead to tissue necrosis. Prompt recognition of chest pain, irregular heart rhythms, or signs of limb ischemia is essential, and the infusion should be adjusted or stopped if these events occur.

Noradrenaline is contraindicated in patients with known hypersensitivity to noradrenaline or any of the formulation excipients. Caution is advised in individuals with severe peripheral vascular disease, uncontrolled tachyarrhythmias, or acute myocardial infarction, as the drug may exacerbate these conditions. Clinical judgment should guide use in such populations.